Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
IMCC · Nasdaq · United States · Medicinal Chemicals & Botanical Products
In shortIM Cannabis Corp. is loss-making.
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -21.2% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -20.7% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -1496.2% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -79.3% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 0.67× | 0/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | – | 0/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -3.31× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | -32.65 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 8.6% | 54/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 1 of 5 | 0/100 |
Weight in the score: 20%
| Profitable years (last 5) | 0 of 5 | 0/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 51.6% | 0/100 |
| Operating margin volatility | 22.4% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 0.2% | 18/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
2 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
CAD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 34 | 54 | 49 | 54 | 55 |
| Cost of revenue | 25 | 43 | 38 | 46 | 45 |
| Gross profit | 6.3 | 9.2 | 9.8 | 8.5 | 9.7 |
| Operating income | (23) | (31) | (13) | (10) | (12) |
| Interest expense | 0.7 | 2 | 3.7 | 4.8 | 3.5 |
| Pre-tax income | (0.2) | (26) | (9.5) | (13) | (12) |
| Income tax | 0.5 | (1.1) | 0.8 | (1) | 0.1 |
| Net income | (18) | (189) | (9.5) | (11) | (11) |
| Diluted EPS | −C$6.70 | −C$161.88 | −C$4.45 | −C$4.51 | −C$2.67 |
| Diluted shares (millions) | 6 | 7.5 | 13 | – | – |
2 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 reported quarters (10-Q and 10-K filings), in CAD millions. The fourth quarter is derived from the annual report.
The last 5 quarters of IM Cannabis Corp. are included in the Investor plan. Try free for 7 days →
−32.65 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
4/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2025 · Data updated Mar 30, 2026